Stock 2126 JW (CAYMAN) THERAPEUTICS CO. LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company JW (Cayman) Therapeutics Co. Ltd

Equities

2126

KYG5210T1040

Biotechnology & Medical Research

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:20 26/04/2024 BST 		5-day change 1st Jan Change
1.7 HKD -2.86% Intraday chart for JW (Cayman) Therapeutics Co. Ltd -1.16% -24.78%
03-20 JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023 MT
03-20 JW Therapeutics Co. Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

JW Cayman Therapeutics Co Ltd is a China-based company mainly engaged in the clinical and pre-clinical stage cell therapy. The Company is focuses on developing cell therapies for the China market to transform the treatment of cancer for Chinese patients. Through its subsidiary, it has built an integrated platform focused on developing, manufacturing and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its main product candidate, relmacabtagene autoleucel (relma-cel), is an autologous anti-CD19 CAR-T therapy for relapsed or refractory (r/r) B-cell lymphoma. The Company mainly conducts its businesses in the China market.

Number of employees: 398

Sales per Business

HKD in Million2021Weight2022Weight Delta
Anti-tumor Drugs
100.0 %
37 100.0 % 169 100.0 % +356.49%

Sales per region

HKD in Million2021Weight2022Weight Delta
China
100.0 %
37 100.0 % 169 100.0 % +356.49%

Managers

Managers TitleAgeSince
Yi Ping Li CEO
 Chief Executive Officer 59 05/09/17
Shaun Paul Cordoba CTO
 Chief Tech/Sci/R&D Officer 43 09/01/22
Mark Gilbert CTO
 Chief Tech/Sci/R&D Officer 63 -
Hong Xia Zheng PRN
 Corporate Officer/Principal 55 17/02/19
Ka Man Ng SEC
 Corporate Secretary - 16/12/21
Raymond Joseph Hage PRN
 Corporate Officer/Principal 56 09/01/22

Members of the board

Members of the board TitleAgeSince
Debra Yu BRD
 Director/Board Member 59 28/02/23
Cheng Liu BRD
 Director/Board Member 57 29/06/20
Yi Ping Li CEO
 Chief Executive Officer 59 05/09/17
Kin Cheong Ho BRD
 Director/Board Member 56 21/10/20
Yiu Leung Cheung BRD
 Director/Board Member 64 21/10/20
Krishna Viswanadhan
- -
Ann Li Lee BRD
 Director/Board Member 63 21/05/20
Xing Gao BRD
 Director/Board Member 39 21/05/20
Krishnan Viswanadhan BRD
 Director/Board Member 46 19/11/19
Sung Won Song BRD
 Director/Board Member 43 28/08/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 414,358,958 316,073,890 ( 76.28 %) 0 76.28 %

Shareholders

NameEquities%Valuation
Yi Ping Li
5.337 %
22,042,212 5.337 % 5 M $
Bosera Asset Management Co., Ltd.
0.6206 %
2,563,000 0.6206 % 599 281 $
Atlantis Investment Management Ltd. /Hong Kong/
0.0368 %
152,000 0.0368 % 35 541 $
PMG Investment Solutions AG
0.0312 %
129,000 0.0312 % 30 163 $
Dimensional Fund Advisors Ltd.
0.0261 %
107,897 0.0261 % 25 228 $
China Asset Management (Hong Kong) Ltd.
0.004359 %
18,000 0.004359 % 4 209 $
Da Cheng Fund Management Co., Ltd.
0.000242 %
1,000 0.000242 % 234 $
DFA Australia Ltd.
0.000207 %
855 0.000207 % 200 $

Company contact information

JW (Cayman) Therapeutics Co. Ltd.

Building B No. 699 Zhong Ke Road

200120, Shanghai

+

http://www.jwtherapeutics.com
address JW (Cayman) Therapeutics Co. Ltd(2126)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Ratings for JW (Cayman) Therapeutics Co. Ltd

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.574 CNY
Average target price
2.508 CNY
Spread / Average Target
+59.38%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
JW (CAYMAN) THERAPEUTICS CO. LTD Stock JW (Cayman) Therapeutics Co. Ltd
-24.78% 87.63M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.74B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 2126 Stock
  4. Company JW (Cayman) Therapeutics Co. Ltd